Suchergebnisse - "Hall, Michael J"

PubPharm (10)

1

Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers : A Multicenter Analysis

enthalten in: The American journal of gastroenterology | 2022

von Stanich, P. | Elgindi, D. | Stoffel, E. | +15

2

Variation in the risk of colorectal cancer in families with Lynch syndrome : a retrospective cohort study

enthalten in: The Lancet. Oncology | 2021

von International Mismatch Repair Consortium | Win, A. | Dowty, J. | +98

CommentIn: Lancet Oncol. 2021 Jul;22(7):899-901. - PMID 34111420

3

Geographic and Ethnic Heterogeneity of Germline BRCA1 or BRCA2 Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Golan, T. | Kindler, H. | Park, J. | +12

4

A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors

enthalten in: Cancer prevention research (Philadelphia, Pa.) | 2020

von Biller, L. | Ukaegbu, C. | Dhingra, T. | +20

5

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

enthalten in: The New England journal of medicine | 2019

von Golan, T. | Hammel, P. | Reni, M. | +16

CommentIn: Cancer Discov. 2019 Aug;9(8):OF6. - PMID 31164341

6

Preferences for in-person disclosure : Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study

enthalten in: Clinical genetics | 2019

von Beri, N. | Patrick-Miller, L. | Egleston, B. | +30

7

Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results

enthalten in: Journal of the National Cancer Institute | 2018

von Bradbury, A. | Patrick-Miller, L. | Egleston, B. | +29

8

Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT) : Initial Results From a Prospective Multicenter Registry

enthalten in: Chest | 2015

von Kuo, W. | Banerjee, A. | Kim, P. | +9

CommentIn: Chest. 2015 Sep;148(3):e93. - PMID 26324145

9

Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2014

von Konski, A. | Meyer, J. | Joiner, M. | +10

10

Gemcitabine plus sorafenib in patients with advanced pancreatic cancer : a phase II trial of the University of Chicago Phase II Consortium

enthalten in: Investigational new drugs | 2012

von Kindler, H. | Wroblewski, K. | Wallace, J. | +6

1
[1]